Generation of a mouse model for Familial Dysautonomia.
家族性自主神经功能障碍小鼠模型的生成。
基本信息
- 批准号:7069136
- 负责人:
- 金额:$ 7.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-07-01 至 2008-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Familial Dysautonomia (FD) is an autosomal recessive disorder that affects 1/3,600 live births in the Ashkenazi Jewish population. This debilitating disorder is characterized by poor development, survival and progressive degeneration of the sensory and autonomic nervous system. Despite recent advances, the disorder is inevitably fatal, with only 50% of patients reaching the age 30. In FD the major haplotype (>98% of the FD cases), is associated with a T?C transition in position 6 of the donor splice site of intron 20 of the Ikbkap gene (which encodes the IKAP protein). This mutation results in the generation of an mRNA in which exon 20 is spliced out causing a frameshift and producing a truncated protein of 79kD. The normal function of IKAP as well as the mechanisms leading to the progressive degeneration of the nervous system in FD remain unknown. In our proposed studies we will 1) analyze the pattern of expression of Ikbkap in the mouse to identify the tissues where IKAP may play an essential role and 2) generate a mouse model for FD using two strategies: The first strategy consists in replicating the human point mutation in intron 20 of the mouse gene, which should in principle lead to the production of a truncated protein. Potential differences in splicing recognition between the two species may however interfere with the generation of an FD model using this approach. As an alternative strategy, we propose to generate a deletion of exon 20. These two mouse lines will be generated in parallel. A preliminary characterization of these mice will include behavioral, physiological and histopathological analyses. If a successful mouse model is generated it will be made available for the scientific community for further characterization and for testing potential therapeutic strategies.
描述(由申请人提供):家族性自主神经功能障碍(FD)是一种常染色体隐性遗传疾病,影响德系犹太人人口中1/3,600的活产婴儿。这种使人衰弱的疾病的特征是感觉和自主神经系统的发育、存活和进行性退化不良。尽管最近取得了进展,但这种疾病不可避免地是致命的,只有50%的患者达到30岁。在FD中,主要单倍型(>98%的FD病例)与T?Ikbkap基因(编码IKAP蛋白)内含子20供体剪接位点6位的C转换。该突变导致产生mRNA,其中外显子20被剪接掉,引起移码并产生79 kD的截短蛋白。IKAP的正常功能以及导致FD神经系统进行性变性的机制尚不清楚。在我们提出的研究中,我们将1)分析小鼠中Ikbkap的表达模式,以确定IKAP可能发挥重要作用的组织,2)使用两种策略生成FD的小鼠模型:第一种策略包括复制小鼠基因内含子20中的人类点突变,原则上应导致产生截短蛋白。然而,两个物种之间的剪接识别的潜在差异可能会干扰使用这种方法的FD模型的生成。作为替代策略,我们建议产生外显子20的缺失。这两条鼠标线将并行生成。这些小鼠的初步表征将包括行为、生理和组织病理学分析。如果成功地生成了小鼠模型,它将可供科学界进一步表征和测试潜在的治疗策略。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Deletion of exon 20 of the Familial Dysautonomia gene Ikbkap in mice causes developmental delay, cardiovascular defects, and early embryonic lethality.
- DOI:10.1371/journal.pone.0027015
- 发表时间:2011
- 期刊:
- 影响因子:3.7
- 作者:Dietrich P;Yue J;E S;Dragatsis I
- 通讯作者:Dragatsis I
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
IOANNIS DRAGATSIS其他文献
IOANNIS DRAGATSIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('IOANNIS DRAGATSIS', 18)}}的其他基金
Genetic restoration of IKAP as a tool to study Familial Dysautonomia
IKAP 的遗传恢复作为研究家族自主神经功能障碍的工具
- 批准号:
9804600 - 财政年份:2019
- 资助金额:
$ 7.3万 - 项目类别:
Generation of a mouse model for Progressive Supranuclear Palsy
进行性核上性麻痹小鼠模型的生成
- 批准号:
8259429 - 财政年份:2011
- 资助金额:
$ 7.3万 - 项目类别:
Generation of a mouse model for Progressive Supranuclear Palsy
进行性核上性麻痹小鼠模型的生成
- 批准号:
8189541 - 财政年份:2011
- 资助金额:
$ 7.3万 - 项目类别:
Generation of a mouse model for Familial Dysautonomia.
家族性自主神经功能障碍小鼠模型的生成。
- 批准号:
6979728 - 财政年份:2005
- 资助金额:
$ 7.3万 - 项目类别:
相似海外基金
Mechanisms of messenger RNA splicing and RNA processing regulation
信使RNA剪接和RNA加工调控机制
- 批准号:
10623834 - 财政年份:2023
- 资助金额:
$ 7.3万 - 项目类别:
Analysis on how RNA splicing factors change global gene expression patterns and regulate male fertility.
分析RNA剪接因子如何改变全局基因表达模式并调节男性生育能力。
- 批准号:
2882792 - 财政年份:2023
- 资助金额:
$ 7.3万 - 项目类别:
Studentship
Collaborative Research: Connecting the sequence logic of RNA splicing to nuclear localization
合作研究:将 RNA 剪接的序列逻辑与核定位联系起来
- 批准号:
2246530 - 财政年份:2023
- 资助金额:
$ 7.3万 - 项目类别:
Standard Grant
Collaborative Research: Connecting the sequence logic of RNA splicing to nuclear localization
合作研究:将 RNA 剪接的序列逻辑与核定位联系起来
- 批准号:
2246531 - 财政年份:2023
- 资助金额:
$ 7.3万 - 项目类别:
Standard Grant
Aberrant RNA splicing in sporadic inclusion body myositis
散发性包涵体肌炎中的异常RNA剪接
- 批准号:
23K18260 - 财政年份:2023
- 资助金额:
$ 7.3万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Synthetic introns for selective targeting of RNA splicing factor-mutant leukemia
用于选择性靶向RNA剪接因子突变型白血病的合成内含子
- 批准号:
10722782 - 财政年份:2023
- 资助金额:
$ 7.3万 - 项目类别:
Cancer immune therapeutics targeting aberrant RNA splicing products
针对异常 RNA 剪接产物的癌症免疫疗法
- 批准号:
23H02688 - 财政年份:2023
- 资助金额:
$ 7.3万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
RNA splicing regulation during alcohol withdrawal
酒精戒断过程中的 RNA 剪接调节
- 批准号:
10785159 - 财政年份:2023
- 资助金额:
$ 7.3万 - 项目类别:
Targeting Dysregulated RNA Splicing in Neurodegenerative Diseases
靶向神经退行性疾病中失调的 RNA 剪接
- 批准号:
10729566 - 财政年份:2023
- 资助金额:
$ 7.3万 - 项目类别:
Function, composition, and mechanism of RNA splicing factories in cardiomyopathy
RNA剪接工厂在心肌病中的功能、组成和机制
- 批准号:
10583011 - 财政年份:2022
- 资助金额:
$ 7.3万 - 项目类别:














{{item.name}}会员




